Drug Shortage Report for MAR-LACOSAMIDE
Report ID | 137162 |
Drug Identification Number | 02487810 |
Brand name | MAR-LACOSAMIDE |
Common or Proper name | LACOSAMIDE |
Company Name | MARCAN PHARMACEUTICALS INC |
Market Status | DORMANT |
Active Ingredient(s) | LACOSAMIDE |
Strength(s) | 100MG |
Dosage form(s) | TABLET |
Route of administration | ORAL ORAL |
Packaging size | 60 Tablets |
ATC code | N03AX |
ATC description | ANTIEPILEPTICS |
Reason for shortage | Other (Please describe in comments) |
Anticipated start date | 2021-04-09 |
Actual start date | 2021-04-09 |
Estimated end date | 2022-08-31 |
Actual end date | 2022-07-06 |
Shortage status | Resolved |
Updated date | 2023-07-13 |
Company comments | Business reasons |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 2 GURDWARA RD., SUITE 112 OTTAWA, ONTARIO CANADA K2E 1A2 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v7 | 2023-07-13 | French | Compare |
v6 | 2023-07-13 | English | Compare |
v5 | 2021-08-31 | French | Compare |
v4 | 2021-08-31 | English | Compare |
v3 | 2021-04-10 | English | Compare |
v2 | 2021-04-08 | French | Compare |
v1 | 2021-04-08 | English | Compare |
Showing 1 to 7 of 7